These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31976023)

  • 1. Proximal Gastrectomy versus Total Gastrectomy for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Comprehensive Analysis of Data from the SEER Registry.
    Zhu K; Xu Y; Fu J; Mohamud FA; Duan Z; Tan S; Zhao Z; Chen P; Zong L
    Dis Markers; 2019; 2019():9637972. PubMed ID: 31976023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
    Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the therapeutic efficacy of radical gastrectomy in Siewert type Ⅱ and Ⅲ adenocarcinoma of the esophagogastric junction].
    Zheng GL; Zheng ZC; Zhao Y; Zhang T; Zhang JJ
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):538-42. PubMed ID: 27531269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study.
    Huang CM; Lv CB; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
    Surg Endosc; 2017 Sep; 31(9):3495-3503. PubMed ID: 27981384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
    Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
    Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
    J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of laparoscopic total gastrectomy for advanced Siewert type Ⅱ and type Ⅲ esophagogastric junction carcinoma: A propensity score-matched case-control study.
    Zhao Y; Zhang J; Yang D; Tang Z; Wang Q
    Asian J Surg; 2019 Aug; 42(8):805-813. PubMed ID: 30685144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of laparoscopic gastrectomy for patients with Siewert-type II/III adenocarcinoma of the esophagogastric junction: A propensity score matching analysis.
    Shi Y; Li L; Xiao H; Guo S; Wang G; Tao K; Dong J; Zong L
    PLoS One; 2018; 13(9):e0203125. PubMed ID: 30256806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical and survival outcomes after laparoscopic and open gastrectomy for serosa-invasive Siewert type II/III esophagogastric junction carcinoma: a propensity score matching analysis.
    Lin X; Wan J; Li Z; Yan M; Liu J; Shi Y; Qian F; Zhao Y
    Surg Endosc; 2022 Jul; 36(7):5055-5066. PubMed ID: 34761283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximal Gastrectomy Versus Total Gastrectomy for Siewert II/III Adenocarcinoma of the Gastroesophageal Junction: a Systematic Review and Meta-analysis.
    Li X; Gong S; Lu T; Tian H; Miao C; Liu L; Jiang Z; Hao J; Jing K; Yang K; Guo T
    J Gastrointest Surg; 2022 Jun; 26(6):1321-1335. PubMed ID: 35355172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Long-Term Outcomes of Surgery Versus Endoscopic Treatment in Patients With Siewert Type II T1M0N0 Adenocarcinoma of the Esophagogastric Junction.
    Chen H; Yu X; Yang R; Li S; Zhang G; Si X; Zhou X
    Cancer Control; 2022; 29():10732748221143389. PubMed ID: 36523149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction.
    Xiao JW; Liu ZL; Ye PC; Luo YJ; Fu ZM; Zou Q; Wei SJ
    World J Gastroenterol; 2015 Sep; 21(34):9999-10007. PubMed ID: 26379405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary efficacy analysis of Cheng's Giraffe reconstruction after proximal gastrectomy in adenocarcinoma of esophagogastric junction].
    Cheng XD; Xu ZY; Du YA; Hu C; Yu JF; Yang LT; Huang L; Yu PF; Dai GG; Zhang YQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):158-162. PubMed ID: 32074796
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-Term Outcome of Proximal Gastrectomy for Upper-Third Advanced Gastric and Siewert Type II Esophagogastric Junction Cancer Compared With Total Gastrectomy: A Propensity Score-Matched Analysis.
    Lee S; Chae YS; Yun WG; Kim JC; Park JK; Kim MG; Kim J; Cho YS; Kong SH; Park DJ; Lee HJ; Yang HK
    Ann Surg Oncol; 2024 May; 31(5):3024-3030. PubMed ID: 38372863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.
    Lv CB; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH
    Medicine (Baltimore); 2016 May; 95(21):e3473. PubMed ID: 27227913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.